Fair value losses enlarging net losses

Hong Kong IPO disclosure precedents · 133 companies, 133 items

Redemption or repurchase obligations (e.g. put options over Pre-IPO shares) measured at fair value whose fair-value or carrying-amount changes produce losses that materially enlarge the issuer's net loss, including where the obligation is later terminated.

2026-09-29Application Proof
DataCanvas Co., Ltd.北京九章云极科技股份有限公司

In 2023, 2024, 2025 and the six months ended June 30, 2025 and 2026, our losses on changes in fair value of financial liabilities at FVTPL were RMB199.7 million, RMB252.0 million, RMB239.5 million, RMB178.2 million and RMB1,067.8 million, respectively.

Financial Information · p. 197

The warrants and convertible loan notes were fully settled in November 2025 and May 2026, respectively. The paid-in capital/ordinary shares with preferred rights will be reclassified to equity after the termination of the investors' redemption rights upon [REDACTED].

Financial Information · p. 207

Our losses on changes in fair value of financial liabilities at FVTPL increased significantly from RMB178.2 million in the six months ended June 30, 2025 to RMB1,067.8 million in the six months ended June 30, 2026, in relation to changes in the valuation of our Company.

Financial Information · p. 201
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-09-29Application Proof
YUDO HOLDINGS CO., LIMITED柳道实业控股有限公司

On December 12, 2017, we agreed to allot and issue 1,290,000 convertible preference shares of our Company (the “Convertible Preference Shares”) at an aggregate subscription price of US$178.2 million to Match Jersey, an independent third party, and Match Jersey agreed to contribute US$19.8 million to the capital of the Convertible Preference Shares then in issue in the form of a capital surplus increase without changing the total number of outstanding Convertible Preference Shares.

Financial Information · p. 212

(i) we agreed to declare and pay a special dividend in the amount of US$90.0 million (the “Special Dividend”) to Match Jersey as the holder of the Convertible Preference Shares; (ii) subject to the settlement of the Special Dividend, the Convertible Preference Shares were converted into ordinary shares on a one-for-one basis (the “Share Conversion”); and (iii) following the Share Conversion, we bought back an aggregate of 1,290,000 ordinary shares with US$280.0 million (the “Buy-back Arrangement”).

Financial Information · p. 212

Adjusted net profit for the period is calculated by adding the fair value change of convertible preference shares and convertible preference share dividends, which were non-recurring and non-operating in nature, to our profit/(loss) for the period.

Summary · p. 1
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-09-28PHIP
Anhui Sinomags Technology Co., Ltd安徽希磁科技股份有限公司

Since the date of incorporation, our Company has completed several rounds of financing and has granted certain special rights to investors, pursuant to which our Company shall redeem at the request of any investors with preferred rights in the occurrence of certain major events, including, among others, the failure to consummate an [REDACTED] or a strategic transaction of the Group before a designated deadline.

Financial Information · p. 234

In 2023, 2024 and 2025 and the five months ended May 31, 2025 and 2026, change in fair value of redemption liabilities amounted to RMB47.7 million, nil, nil, nil and nil, respectively.

Financial Information · p. 234

The relevant special rights granted to investors were terminated in August 2023, following which the carrying amount of the redemption liabilities had been reclassified to equity.

Financial Information · p. 234
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-09-21Prospectus
Direct Drive Tech Limited本末动力(北京)科技股份有限公司06731.HK

Changes in the carrying amount of the redemption liabilities amounted to a loss of RMB12.3 million, RMB16.8 million, RMB770.1 million, RMB11.2 million and RMB284.6 million in 2023, 2024, 2025 and the six months ended June 30, 2025 and 2026, respectively.

Financial Information · p. 215

The significant increase in net loss in 2025 was primarily driven by non-cash changes in the carrying amount of redemption liabilities of RMB770.1 million, which will be re-designated from liabilities to equity upon Listing.

Summary · p. 12

We measure the financial liabilities at fair value.

Financial Information · p. 198
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-09-14Prospectus
Ligent Technologies, Inc.纳真科技公司09856.HK

We recorded fair value losses on financial liabilities at FVTPL of RMB30.0 million, RMB12.0 million and RMB116.3 million in 2023, 2024 and 2025, respectively.

Financial Information · p. 197

The repurchase obligations were terminated in September 2025 when we and the Pre-IPO Investor terminated the investor’s redemption right.

Financial Information · p. 197

As such, we recognized redemption obligations in favor of these investors in 2025 in the total amount of RMB539.0 million.

Financial Information · p. 220
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-08-24Prospectus
Mech-Mind Robotics Technologies Co., Ltd.梅卡曼德(雄安)机器人科技股份有限公司09615.HK

We recorded changes in the carrying amount of redemption liabilities of RMB57.7 million, RMB60.0 million, RMB209.2 million, RMB29.1 million and RMB10.1 million in 2023, 2024 and 2025 and for the three months ended March 31, 2025 and 2026, respectively.

Financial Information · p. 257

Our changes in the carrying amount of redemption liabilities increased from RMB60.0 million in 2024 to RMB209.2 million in 2025, primarily due to the redemption rights granted to investors in Series D in 2025.

Financial Information · p. 262

We recorded redemption liabilities of RMB2,319.2 million, RMB2,479.2 million, RMB3,055.7 million, RMB3,065.8 million and RMB3,080.9 million, as of December 31, 2023, 2024 and 2025 and March 31, 2026 and July 31, 2026, respectively.

Financial Information · p. 277
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-08-21Application Proof
Qdama International Holding Ltd.钱大妈国际控股有限公司

We recorded fair value gains on CRPS of RMB73.4 million, RMB163.8 million, RMB419.1 million and RMB85.0 million in 2023, 2024, 2025 and the six months ended June 30, 2025, respectively, and recorded fair value losses on CRPS of RMB2.0 million in the six months ended June 30, 2026, mainly reflecting fluctuations in our valuation.

Financial Information · p. 213

The CRPS we issued to Pre-[REDACTED] investors will be re-classified from liabilities to equity as a result of automatic conversion into Ordinary Shares upon [REDACTED].

Financial Information · p. 213

As of December 31, 2023, 2024, 2025 and June 30, 2026, our convertible redeemable preferred shares had fair value of RMB2,292.7 million, RMB2,094.9 million, RMB1,666.7 million and RMB1,641.4 million, respectively.

Financial Information · p. 231
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-08-21Application Proof
Tyligand Bioscience Ltd.泰励生物有限公司

We recorded gains from changes in fair value of financial liabilities at FVTPL of RMB14.8 million for the year ended December 31, 2024, while we recorded loss of RMB46.0 million for the year ended December 31, 2025, primarily due to our Series B Financing and the value increase of our preferred shares to our Pre-[REDACTED] Investors.

Financial Information · p. 248

We recorded loss from changes in fair value of financial liabilities at FVTPL of RMB32.3 million for the six months ended June 30, 2025, while we recorded gains of RMB23.0 million for the six months ended June 30, 2026.

Financial Information · p. 247

Upon the [REDACTED], we do not expect to recognize any further change in fair value of financial liabilities at FVTPL, as the redemption right and the related compulsory liquidation rights will be automatically terminated upon the [REDACTED].

Financial Information · p. 243
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-08-21Application Proof
Zhuhai Kingsware Artificial Intelligence Co., Ltd.珠海金智维人工智能股份有限公司

In 2023, 2024, 2025 and the six months ended June 30, 2025 and 2026, we recorded changes in the carrying amount of redemption liabilities of RMB5.2 million, RMB119.3 million, RMB278.3 million, RMB74.7 million and RMB12.7 million, respectively.

Financial Information · p. 229

Such shares with preferential rights will be re-classified from liabilities to equity upon the [REDACTED].

Financial Information · p. 222

Changes in the carrying amount of redemption liabilities increased significantly from RMB119.3 million in 2024 to RMB278.3 million in 2025, primarily due to changes in the equity value of the Shares with redemption liabilities we issued to Pre-[REDACTED] Investors.

Financial Information · p. 237
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-07-29Application Proof
Shenzhen Yueshi Holding Co., Ltd.深圳粤十控股股份有限公司

A substantial portion of these losses was attributable to changes in the fair value of financial liabilities designated at fair value through profit or loss, arising from the remeasurement of Shares with preferred rights issued by our Company.

Business · p. 182

Following the termination of the redemption obligations and other special rights on December 22, 2025, we no longer recognized changes in the fair value of financial liabilities designated at fair value through profit or loss for the four months ended April 30, 2026, which contributed to our net profit of RMB35.9 million for the same period.

Business · p. 182

All financial liabilities previously designated at fair value through profit or loss were fully converted from liabilities into equity following the termination agreement entered into between our Company and Shareholders on December 22, 2025.

Financial Information · p. 213
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-07-24Application Proof
Guangzhou Novaken Pharm Co., Ltd.广州新济医药股份有限公司

Certain Pre-[REDACTED] Investors were granted by our Company with certain special rights, these series shares with special rights are considered as financial liabilities at fair value through profit or loss and presented as “financial liabilities on series shares”.

Financial Information · p. 245

Our change in fair value of financial liabilities on series shares were approximately RMB120.4 million, RMB29.8 million, RMB1.1 million and RMB161.7 million for the years ended December 31, 2024 and 2025 and the five months ended May 31, 2025 and 2026, respectively.

Financial Information · p. 245

Our change in fair value of financial liabilities on series shares decreased from approximately RMB120.4 million for the year ended December 31, 2024 to approximately RMB29.8 million for the year ended December 31, 2025 primarily due to the increase in our valuation during the period as a result of the progress of development in our Core Products.

Financial Information · p. 250
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-07-19Application Proof
Aulton New Energy Co., Ltd.奥动新能源股份有限公司

Our redemption liabilities were RMB3,793.9 million as of December 31, 2023.

Financial Information · p. 215

Losses from changes in the carrying amount of redemption liabilities decreased from RMB281.0 million in 2023 to RMB121.1 million in 2024, primarily because we entered into a termination agreement for the redemptions rights in May 2024.

Financial Information · p. 196

Changes in the carrying amount of redemption liabilities decreased by 100% from RMB121.1 million in 2024 to nil in 2025, primarily because the relevant redemption rights under the equity financing arrangements were terminated pursuant to termination agreements entered into with the relevant investors in May 2024, and no redemption liabilities were recognized thereafter.

Financial Information · p. 202
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-07-16Application Proof

Our fair value changes on convertible redeemable preferred shares and warrant liability amounted to RMB313.9 million, RMB369.8 million, RMB326.0 million, RMB178.3 million and RMB75.8 million in 2023, 2024, 2025 and five months ended May 31, 2025 and 2026, respectively.

Financial Information · p. 239

These Preferred Shares will be converted into Ordinary Shares upon [REDACTED], after which the amount of our financial liabilities at fair value through profit or loss will be derecognized from our liabilities and recorded as equity.

Financial Information · p. 248

Convertible redeemable preferred shares increased from RMB1,510.3 million as of December 31, 2023 to RMB1,956.1 million as of December 31, 2024, and further increased to RMB2,276.0 million as of December 31, 2025 and RMB2,314.8 million as of May 31, 2026, primarily due to changes in fair value of our convertible redeemable preferred shares.

Financial Information · p. 249
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-07-08Application Proof
Ming Yu Pharmaceutical Limited明宇制药有限公司

During the Track Record Period, we recorded fair value loss in our financial liabilities at FVTPL of RMB14.0 million, RMB927.8 million, RMB249.5 million and RMB79.9 million in 2024, 2025 and the five months ended May 31, 2025 and 2026, respectively.

Financial Information · p. 225

These changes primarily reflect adjustments in our valuation.

Financial Information · p. 225
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-06-29Prospectus

We recorded change in fair value of Preferred Shares and other financial liabilities in the amount of RMB1,190.1 million, RMB1,967.5 million and RMB2,842.9 million in 2023, 2024 and 2025, respectively.

Financial Information · p. 262

We recorded Preferred Shares and other financial liabilities in the amount of RMB16,322.1 million, RMB19,070.5 million and RMB29,810.2 million as of December 31, 2023, 2024, and 2025, respectively.

Financial Information · p. 274

Upon the completion of the Listing, all of such Preferred Shares will be automatically converted into ordinary shares.

Financial Information · p. 278
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-06-29Application Proof
Shengwei Times Technology Co., Ltd.盛威时代科技股份有限公司

(1) investors | 464,054 | 366,967 | 78,016 | 5,779 | 17,782

Summary · p. 8

The redemption rights is expected to be terminated upon [REDACTED], and the redemption rights issued to investors is expected to be reclassified from liabilities to equity accordingly.

Summary · p. 8

Our net losses were also significantly affected by certain non-cash or non-recurring items, including (i) changes in the carrying amounts of redemption rights issued to investors, (ii) equity-settled share-based payments and (iii) [REDACTED].

Financial Information · p. 229
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-06-29Prospectus
EACON Group Co., Ltd易控智驾科技股份有限公司07687.HK

During the Track Record Period, our fair value changes on financial liabilities at FVTPL amounted to RMB33.5 million, RMB66.1 million, and nil in 2023, 2024, 2025, respectively.

Financial Information · p. 219

Our fair value changes on financial liabilities at FVTPL increased by RMB32.6 million, or 97.3% from RMB33.5 million in 2023 to RMB66.1 million in 2024, primarily attributable to the fair value changes in our shares with preferred rights classified as financial liabilities, driven by adjustments in valuation assumptions related to our improving business outlook, higher projected performances, and increased probability of a liquidity event such as an initial public offering.

Financial Information · p. 225

In 2024, our financial position improved from net liabilities of RMB812.5 million as of December 31, 2023 to net assets of RMB260.0 million as of December 31, 2024, primarily attributable to the conversion of substantially all historical rounds of shares with preferred rights into ordinary shares of RMB1,415.7 million and additional capital contributions from shareholders, partially offset by a loss and total comprehensive expense of RMB390.6 million.

Summary · p. 7
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-06-29Application Proof

We recorded fair value losses of convertible redeemable preferred shares of RMB73.0 million, RMB76.2 million and RMB147.8 million in 2023, 2024 and 2025, respectively, resulting from the increase in fair value of convertible redeemable preferred shares.

Financial Information · p. 227

On May 30, 2025, we reached an agreement with the holders of the convertible redeemable preferred shares that we repurchased 3,454,613 Series D Preferred Shares at a total consideration of USD24,000,000 in June 2025 and the holders would not exercise the redemption rights to request us to repurchase their outstanding Preferred Shares on or before December 31, 2026.

Financial Information · p. 244

We do not expect to recognize any further fair value gain or loss on convertible redeemable preferred shares in the future upon [REDACTED].

Financial Information · p. 244
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-06-25Application Proof
Hangzhou Lygo Technology Co., Ltd.杭州灵卡科技股份有限公司

We recorded losses from fair value changes of financial liabilities through profit or loss of RMB83.2 million, RMB12.3 million and RMB165.3 million in 2023, 2024 and 2025, respectively, primarily attributable to changes in the valuation of our Company.

Financial Information · p. 212

Our fair value loss on financial liabilities represents changes in the carrying amount of our equity share with redemption rights issued to pre-[REDACTED] investors.

Financial Information · p. 212

We do not expect to record any further fair value losses of financial liabilities at fair value through profit or loss upon the [REDACTED] as such issuance of equity shares with redemption rights will be re-designated and reclassified from liabilities to equity as a result of the termination of the redemption rights upon the [REDACTED].

Financial Information · p. 206
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-06-25Application Proof
WinHealth International Holding Group Company Limited维健国际控股集团有限公司

Our fair value change in financial instruments issued to investors were RMB10.3 million, RMB47.4 million and RMB238.2 million, respectively, for the years ended December 31, 2023, 2024 and 2025.

Financial Information · p. 235

The fair values of the convertible redeemable preferred shares and convertible loans measured at fair value through profit or loss are determined using the valuation technique of hybrid approach, combining the discounted cash flow method, the backsolve method and the option-pricing method.

Financial Information · p. 223

These preferred shares will be reclassified from liabilities to equity as a result of the conversion into ordinary shares upon the [REDACTED]. Subsequently, we do not expect to record any further fair value change in financial instruments issued to investors.

Financial Information · p. 238
The company's explanation, the adviser's view and the page in the filing: see Matters
1 / 7

Tell us